ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B01AC27 | B | Selexipag - 400mcg | 10402 | 14520/1 | UPTRAVI | 400mcg | 60 | Tablet, film coated | Oral | Mersaco | Excella GmbH & Co KG | Germany | 4,512,270 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B01AC27 | B | Selexipag - 400mcg | 10402/945 | 14520/1 | UPTRAVI | 400mcg | 60 | Tablet, film coated | Oral | Mersaco | Excella GmbH & Co KG | Germany | 275,097,581 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 2/5/2024 | 0 |